• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发现对耐药革兰氏阴性菌具有活性的新型抗菌噻吩衍生物。

Discovery of new antimicrobial thiophene derivatives with activity against drug-resistant Gram negative-bacteria.

作者信息

Molina-Panadero Irene, Morales-Tenorio Marcos, García-Rubia Alfonso, Ginex Tiziana, Eskandari Khalil, Martinez Ana, Gil Carmen, Smani Younes

机构信息

Andalusian Center of Developmental Biology, CSIC, University of Pablo de Olavide - Seville, Seville, Spain.

Centro de Investigaciones Biológicas Margarita Salas (CIB-CSIC), Madrid, Spain.

出版信息

Front Pharmacol. 2024 Aug 20;15:1412797. doi: 10.3389/fphar.2024.1412797. eCollection 2024.

DOI:10.3389/fphar.2024.1412797
PMID:39228527
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11368766/
Abstract

Our aim is to identify new small molecules with antimicrobial potential, especially against colistin-resistant (Col-R) and . After initial hits identification by fingerprint similarity, MIC of 24 heterocyclic derivatives for and reference strains, and bactericidal activity of selected thiophenes against Col-R strains were determined. We analyzed changes in bacterial membrane permeability and the OMPs profile. Additionally, we determined bacterial adherence to host cells and performed molecular docking studies to assess their binding to bacterial targets. The compounds' MICs ranged from 4 to >64 mg/L. Thiophene derivatives , and exhibited MIC values between 16 and 32 mg/L for Col-R and 8 and 32 mg/L for Col-R . The time-kill curve assay demonstrated that thiophenes and had bactericidal effects against Col-R and . Furthermore, treatment with them resulted in increased membrane permeabilization and reduced adherence of these isolates to host cells. Finally, the docking studies showed a stronger binding affinity to CarO1 and Omp33 of and OmpW and OmpC of . These findings indicate that thiophene derivatives possess antibacterial activity against Col-R and , suggesting that they may enhance the repertoire of drug treatments against bacteria.

摘要

我们的目标是鉴定具有抗菌潜力的新型小分子,尤其是针对耐黏菌素(Col-R)的细菌。通过指纹相似性初步筛选出命中化合物后,测定了24种杂环衍生物对参考菌株的最低抑菌浓度(MIC),并测定了所选噻吩对Col-R菌株的杀菌活性。我们分析了细菌膜通透性和外膜蛋白(OMPs)谱的变化。此外,我们测定了细菌对宿主细胞的黏附情况,并进行了分子对接研究以评估它们与细菌靶点的结合。这些化合物的MIC范围为4至>64mg/L。噻吩衍生物、和对Col-R的MIC值在16至32mg/L之间,对Col-R的MIC值在8至32mg/L之间。时间杀菌曲线分析表明,噻吩和对Col-R和具有杀菌作用。此外,用它们处理会导致这些分离株的膜通透性增加,对宿主细胞的黏附减少。最后,对接研究表明,对CarO1和Omp33的结合亲和力更强,对OmpW和OmpC的结合亲和力更强。这些发现表明,噻吩衍生物对Col-R和具有抗菌活性,表明它们可能会增加抗细菌药物治疗的种类。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949a/11368766/9a5905189238/fphar-15-1412797-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949a/11368766/4fa15eef02a2/fphar-15-1412797-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949a/11368766/9ca9099372f8/fphar-15-1412797-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949a/11368766/75a933e984fc/fphar-15-1412797-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949a/11368766/93b00c95dbbe/fphar-15-1412797-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949a/11368766/9a5905189238/fphar-15-1412797-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949a/11368766/4fa15eef02a2/fphar-15-1412797-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949a/11368766/9ca9099372f8/fphar-15-1412797-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949a/11368766/75a933e984fc/fphar-15-1412797-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949a/11368766/93b00c95dbbe/fphar-15-1412797-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/949a/11368766/9a5905189238/fphar-15-1412797-g005.jpg

相似文献

1
Discovery of new antimicrobial thiophene derivatives with activity against drug-resistant Gram negative-bacteria.发现对耐药革兰氏阴性菌具有活性的新型抗菌噻吩衍生物。
Front Pharmacol. 2024 Aug 20;15:1412797. doi: 10.3389/fphar.2024.1412797. eCollection 2024.
2
Diclofenac Sodium Restores the Sensitivity of Colistin-Resistant Gram-Negative Bacteria to Colistin.双氯芬酸钠恢复了对粘菌素耐药革兰氏阴性菌对粘菌素的敏感性。
ACS Infect Dis. 2024 Aug 9;10(8):2860-2869. doi: 10.1021/acsinfecdis.4c00207. Epub 2024 Jul 29.
3
The anthelmintic oxyclozanide restores the activity of colistin against colistin-resistant Gram-negative bacilli.奥克氯挫钠这种驱虫药可恢复多黏菌素对耐多黏菌素革兰氏阴性菌的活性。
Int J Antimicrob Agents. 2019 Oct;54(4):507-512. doi: 10.1016/j.ijantimicag.2019.07.006. Epub 2019 Jul 9.
4
In vitro and in vivo assessment of the antibacterial activity of colistin alone and in combination with other antibiotics against Acinetobacter baumannii and Escherichia coli.体外和体内评估粘菌素单独和与其他抗生素联合使用对鲍曼不动杆菌和大肠杆菌的抗菌活性。
J Glob Antimicrob Resist. 2020 Mar;20:351-359. doi: 10.1016/j.jgar.2019.09.013. Epub 2019 Sep 23.
5
In vitro and in vivo enhancement effect of glabridin on the antibacterial activity of colistin, against multidrug resistant Escherichia coli strains.甘草素对黏菌素抗多重耐药大肠杆菌的体外和体内增效作用。
Phytomedicine. 2024 Jul 25;130:155732. doi: 10.1016/j.phymed.2024.155732. Epub 2024 May 13.
6
Repositioning rafoxanide to treat Gram-negative bacilli infections.重新定位雷复尼特用于治疗革兰氏阴性杆菌感染。
J Antimicrob Chemother. 2020 Jul 1;75(7):1895-1905. doi: 10.1093/jac/dkaa103.
7
Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant and .尼氯硝唑与黏菌素联合用药对黏菌素敏感和耐药的 和 的协同作用
Front Cell Infect Microbiol. 2018 Oct 3;8:348. doi: 10.3389/fcimb.2018.00348. eCollection 2018.
8
In-Vitro Evaluation of Different Antimicrobial Combinations with and without Colistin Against Carbapenem-Resistant .体外评估含或不含黏菌素的不同抗菌药物组合对碳青霉烯类耐药肠杆菌科细菌的效果
Molecules. 2019 Mar 3;24(5):886. doi: 10.3390/molecules24050886.
9
Antiparasitic nitazoxanide potentiates colistin against colistin-resistant and and .抗寄生虫硝唑尼特增强黏菌素对黏菌素耐药的 和 。
Microbiol Spectr. 2024 Jan 11;12(1):e0229523. doi: 10.1128/spectrum.02295-23. Epub 2023 Nov 30.
10
SAR investigation and optimization of benzimidazole-based derivatives as antimicrobial agents against Gram-negative bacteria.苯并咪唑类衍生物作为抗革兰氏阴性菌抗菌剂的 SAR 研究与优化。
Eur J Med Chem. 2023 Feb 5;247:115040. doi: 10.1016/j.ejmech.2022.115040. Epub 2022 Dec 22.

引用本文的文献

1
Coumarin hybrids: dual-target candidates for future antimicrobial and antitubercular therapies.香豆素杂合物:未来抗菌和抗结核治疗的双靶点候选物。
Future Med Chem. 2025 May;17(10):1131-1142. doi: 10.1080/17568919.2025.2504331. Epub 2025 May 12.
2
War and peace: exploring microbial defence systems as a source of new antimicrobial therapies.战争与和平:探索微生物防御系统作为新型抗菌疗法的来源
Front Pharmacol. 2025 Jan 7;15:1504901. doi: 10.3389/fphar.2024.1504901. eCollection 2024.

本文引用的文献

1
MBC and ECBL libraries: outstanding tools for drug discovery.MBC和ECBL文库:药物发现的杰出工具。
Front Pharmacol. 2023 Aug 11;14:1244317. doi: 10.3389/fphar.2023.1244317. eCollection 2023.
2
Role of bla and OmpC in the piperacillin-tazobactam resistance evolution by E. coli in patients with complicated intra-abdominal infection.bla 和 OmpC 在复杂性腹腔感染患者大肠埃希菌中产广谱β-内酰胺酶和外膜孔蛋白 C 导致哌拉西林-他唑巴坦耐药中的作用。
J Infect. 2023 Sep;87(3):220-229. doi: 10.1016/j.jinf.2023.07.005. Epub 2023 Jul 11.
3
Anthelmintic Drugs for Repurposing against Gram-Negative Bacilli Infections.
用于重新利用以对抗革兰氏阴性杆菌感染的驱虫药。
Curr Med Chem. 2022;30(1):59-71. doi: 10.2174/0929867329666220714092916.
4
Thiophene-containing compounds with antimicrobial activity.含噻吩的具有抗菌活性的化合物。
Arch Pharm (Weinheim). 2022 Jun;355(6):e2100462. doi: 10.1002/ardp.202100462. Epub 2022 Mar 15.
5
Artificial intelligence-enabled virtual screening of ultra-large chemical libraries with deep docking.基于深度对接的人工智能辅助超大规模化学库虚拟筛选。
Nat Protoc. 2022 Mar;17(3):672-697. doi: 10.1038/s41596-021-00659-2. Epub 2022 Feb 4.
6
Targeting bacterial outer-membrane remodelling to impact antimicrobial drug resistance.靶向细菌外膜重塑以影响抗菌药物耐药性。
Trends Microbiol. 2022 Jun;30(6):544-552. doi: 10.1016/j.tim.2021.11.002. Epub 2021 Dec 3.
7
Impact of the COVID-19 Pandemic on Survival in the Patients With the Intra-Abdominal Infections.2019年冠状病毒病大流行对腹腔内感染患者生存的影响。
Front Med (Lausanne). 2021 Oct 20;8:687415. doi: 10.3389/fmed.2021.687415. eCollection 2021.
8
Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections.他莫昔芬代谢物的再利用治疗耐甲氧西林金黄色葡萄球菌和万古霉素耐药粪肠球菌感染。
Microbiol Spectr. 2021 Oct 31;9(2):e0040321. doi: 10.1128/Spectrum.00403-21. Epub 2021 Oct 20.
9
Potential Tamoxifen Repurposing to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli.他莫昔芬可能重新用于对抗多重耐药革兰氏阴性杆菌感染。
Pharmaceuticals (Basel). 2021 May 26;14(6):507. doi: 10.3390/ph14060507.
10
Is drug repurposing really the future of drug discovery or is new innovation truly the way forward?药物重新利用真的是药物研发的未来吗?还是全新的创新才是真正的前进方向?
Expert Opin Drug Discov. 2021 Aug;16(8):829-831. doi: 10.1080/17460441.2021.1912733. Epub 2021 Apr 23.